Circassia Pharmaceuticals (GB:NIOX) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
NIOX Group PLC has successfully completed its tender offer, purchasing 26.25 million ordinary shares at 80 pence each, returning approximately £21 million to shareholders. This move, involving significant shareholders like Harwood Capital and AstraZeneca, is deemed a related party transaction but is considered fair by independent directors. Post-tender, the company will have 397.88 million shares with voting rights, providing a new baseline for shareholder interest calculations.
For further insights into GB:NIOX stock, check out TipRanks’ Stock Analysis page.